YANG Ting
School of Pharmaceutical Science, University of South China, Hengyang, Hunan 421000, China;Department of Pharmacy, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421000, ChinaLAI Qi
School of Pharmaceutical Science, University of South China, Hengyang, Hunan 421000, China;Department of Pharmacy, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421000, ChinaYANG Jun
Department of Cardiology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421000, ChinaCHU Chun
School of Pharmaceutical Science, University of South China, Hengyang, Hunan 421000, China;Department of Pharmacy, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421000, China1.School of Pharmaceutical Science, University of South China, Hengyang, Hunan 421000, China;2.Department of Pharmacy, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421000, China;3.Department of Cardiology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421000, China)
R966;R5
YANG Ting, LAI Qi, YANG Jun, CHU Chun. Effect of the mitochondrial H2S donor AP39 on myocardial fibrosis in rats with myocardial infarction and its relationship to mitochondrial dynamics[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2024,32(6):473-480.
Copy